Prodrug strategies for antihypertensives

Area of Science:

• Pharmacology
• Medicinal Chemistry

Background:

• Hypertension significantly contributes to cardiovascular disease burden.
• Current antihypertensive drugs often exhibit poor oral bioavailability, short action duration, and first-pass metabolism.
• These limitations necessitate the development of improved drug delivery strategies.

Purpose of the Study:

• To review prodrug design and development strategies for antihypertensive agents.
• To highlight the rationale, structural modifications, and achieved outcomes of antihypertensive prodrugs.
• To provide an overview of recent advancements in antihypertensive prodrug research.

Main Methods:

• Literature review of prodrug strategies for various antihypertensive classes.
• Analysis of prodrug synthesis, structural modifications, and their impact on drug properties.
• Examination of research advances in the field.

Main Results:

• Prodrugs offer a viable approach to overcome pharmacokinetic limitations of existing antihypertensives.
• Various prodrug strategies have been successfully employed to improve drug efficacy and reduce toxicity.
• Significant progress has been made in developing novel antihypertensive prodrugs.

Conclusions:

• Prodrug development is crucial for optimizing antihypertensive therapy.
• Targeted prodrug design can effectively address challenges like poor bioavailability and short duration of action.
• Continued research in antihypertensive prodrugs promises enhanced cardiovascular disease management.